Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of Hyperhidrosis
The Food and Drug Administration (FDA) is classifying the skin patch for treatment of hyperhidrosis...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- June 30, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA) is classifying the skin patch for treatment of hyperhidrosis...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Drug label update: Evereden Kids Mineral Sunscreen SPF 30
Official structured record identifier: bba219a4-de83-76fd-e053-2995a90a2d69.
Drug label update: GUNA-VIRUS
Official structured record identifier: 53e741c4-8897-71f3-e063-6394a90a751d.
UKHSA Evaluation Strategy
This Evaluation Strategy sets out UKHSA’s organisation‑wide approach to planning, conducting and usi...